ATE4170T1 - Impfstoff zum verhueten von durch den katzenleuk[mievirus verursachter chronischer virusaemie bei katzen und verfahren zu seiner herstellung. - Google Patents

Impfstoff zum verhueten von durch den katzenleuk[mievirus verursachter chronischer virusaemie bei katzen und verfahren zu seiner herstellung.

Info

Publication number
ATE4170T1
ATE4170T1 AT80104255T AT80104255T ATE4170T1 AT E4170 T1 ATE4170 T1 AT E4170T1 AT 80104255 T AT80104255 T AT 80104255T AT 80104255 T AT80104255 T AT 80104255T AT E4170 T1 ATE4170 T1 AT E4170T1
Authority
AT
Austria
Prior art keywords
vaccine
feline
virus
leukmy
viralemia
Prior art date
Application number
AT80104255T
Other languages
English (en)
Inventor
Niels Christian Dr. Pedersen
Gordon Henry Dr. Theilen
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Application granted granted Critical
Publication of ATE4170T1 publication Critical patent/ATE4170T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT80104255T 1979-08-01 1980-07-18 Impfstoff zum verhueten von durch den katzenleuk[mievirus verursachter chronischer virusaemie bei katzen und verfahren zu seiner herstellung. ATE4170T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/062,737 US4264587A (en) 1979-08-01 1979-08-01 Vaccine for preventing persistent feline leukemia viremia in cats
EP80104255A EP0024541B1 (de) 1979-08-01 1980-07-18 Impfstoff zum Verhüten von durch den Katzen-Leukämievirus verursachter chronischer Virusämie bei Katzen und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ATE4170T1 true ATE4170T1 (de) 1983-08-15

Family

ID=22044472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80104255T ATE4170T1 (de) 1979-08-01 1980-07-18 Impfstoff zum verhueten von durch den katzenleuk[mievirus verursachter chronischer virusaemie bei katzen und verfahren zu seiner herstellung.

Country Status (5)

Country Link
US (1) US4264587A (de)
EP (1) EP0024541B1 (de)
AT (1) ATE4170T1 (de)
CA (1) CA1155763A (de)
DE (1) DE3064259D1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522810A (en) * 1982-12-09 1985-06-11 The Regents Of The University Of California Feline calicivirus vaccine
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US5152982A (en) * 1984-03-26 1992-10-06 Chiron Corporation Compositions and methods for FeLV vaccination
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
US5352449A (en) * 1986-05-30 1994-10-04 Cambridge Biotech Corporation Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant
NZ220500A (en) * 1986-05-30 1991-05-28 Cambridge Bioscience Corp Recombinant felv polypeptide; vaccine and expression vectors
US4861720A (en) * 1986-07-03 1989-08-29 Regents Of The University Of California Oncornavirus vaccines and feline alpha-type interferon
US5306493A (en) * 1986-10-03 1994-04-26 Miles Inc. FeLV-infected feline cell line
US5374424A (en) * 1986-10-03 1994-12-20 Miles Inc. Multivalent felv-infected feline vaccine
CA2005311C (en) * 1988-12-13 2006-05-30 Edward A. Hoover Prototype felv isolates for use in disease models and vaccines
FR2677654B1 (fr) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
WO1993004698A1 (en) * 1991-08-29 1993-03-18 Smithkline Beecham Corporation Method of enhancing anti-rabies immune responses
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
CA2681183A1 (en) * 2007-05-30 2008-12-11 Wyeth Raccoon poxvirus expressing genes of feline antigens
ES2728949T3 (es) 2008-06-27 2019-10-29 Zoetis Services Llc Composiciones adyuvantes novedosas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
GB1486186A (en) * 1973-09-18 1977-09-21 Univ Glasgow Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
US4034081A (en) * 1973-09-18 1977-07-05 University Of Glasgow Vaccines against feline leukemia

Also Published As

Publication number Publication date
DE3064259D1 (en) 1983-08-25
EP0024541B1 (de) 1983-07-20
EP0024541A2 (de) 1981-03-11
US4264587A (en) 1981-04-28
CA1155763A (en) 1983-10-25
EP0024541A3 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
ATE4170T1 (de) Impfstoff zum verhueten von durch den katzenleuk[mievirus verursachter chronischer virusaemie bei katzen und verfahren zu seiner herstellung.
ATE7689T1 (de) 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
DE2861729D1 (en) Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
JPS51143673A (en) New derivatives of 4-aminopiperidines
ATE35827T1 (de) Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen.
ATE8892T1 (de) Substituierte azabicyclooctancarboxylsaeure, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
JPS5423115A (en) Gamma-globulin for intravenous injection and its preparation
DK84181A (da) Derivater af 3,4,5-trihydroxypiperidin,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler samt til dyreernaering
FI92650B (fi) Menetelmä ihon kautta tapahtuvaa virtausta lisäävän farmaseuttisen valmisteen valmistamiseksi
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DK160556C (da) Benzodioxinpyrrolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
AT355859B (de) Verfahren zur behandlung von veterinaermedizi- nischen praeparaten zur oralen aufnahme durch tiere
PT77238A (de) Substituierte tert.-butanol-derivate verfahren zu ihrer herstellung und diese enthaltende antimykotische mittel
ES258463A1 (es) Un procedimiento de preparar una vacuna trivalente viva contra la poliomelitis
DE58907341D1 (de) Cyclische Azaaliphaten mit Nitroxyfunktion, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel.
DE3578135D1 (de) Behandlung eines ultrafiltrats durch elektrodialyse.
ATE35259T1 (de) Triazinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, welche diese enthalten.
FR2447950B1 (fr) Procede de melange de copolymeres ethylene/acetate de vinyle et de gommes de polydiorganosiloxane et melange obtenu par ce procede
ES472528A1 (es) Procedimiento para la preparacion de derivados de benzosul- fonamida
DE69530779T2 (de) Muramylpeptide zusammensetzungen für inhibierung von hiv replikation
JPS5639019A (en) Antiviral agent
NL930060I1 (nl) Neuromusculaire blokkerende middelen met lange werking farmaceutische mengsels welke deze bevatten en werkwijzen ter bereiding daarvan
DE3887626D1 (de) 2-Oxa-isocephem-Verbindungen, diese enthaltende Zusammensetzungen und Verfahren zu deren Herstellung.
JPS5253823A (en) Aniline derivative* preparation thereof* microbicide containing said compound and method of combating microorganisms by using said microbicide
ES8401095A1 (es) Procedimiento para la preparacion de 11 -cloro-15-esteroides.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification